CClinicalTrials.gg
Status unknownNCT04326621Updated Mar 30, 2020

Effectiveness of Pressure Release Technique in Patients With Chronic Low Back Pain

An interventional study of Pressure Release Technique (PRT) and Control in Low Back Pain, sponsored by Universidad Complutense de Madrid. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-03-30.

Sponsored by Universidad Complutense de Madrid · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2020), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A Pressure Release Technique will be test in patient with low back pain compared to a sham

02

Conditions studied

  • Low Back Pain
03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

This study's planned enrollment of 16 is below the median of 60 across 1,941 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

Universidad Complutense de Madrid is the lead sponsor of 200 studies on the registry; 60 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • chronic low back pain at least 6 months

Exclusion criteria

Exclusion Criteria:

  • hernia, neurologic pain
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
16 participants (estimated)

Study arms

  • Experimental
    PRT group

    pressure Release Technique and exercises

    Other: Pressure Release Technique (PRT) · Other: Control

  • Active comparator
    Exercises group

    Only exercises

    Other: Pressure Release Technique (PRT) · Other: Control

Interventions

  • OtherPressure Release Technique (PRT)

    A pressure applied on muscles trigger points with the finger of a physiotherapist and exercises

  • OtherControl

    exercises

06

What researchers measure

Primary outcomes

  1. VAS

    self reported pain

    Time frame: immediately after treatment

  2. VAS

    self reported pain

    Time frame: at 6 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 30, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04326621
Lead sponsor
Universidad Complutense de Madrid
Responsible party
Gema Serrano-Hernanz (PhD, Universidad Complutense de Madrid) — Principal investigator
First posted
Mar 30, 2020
Start date
Sep 2020 (estimated)
Primary completion
Jan 2021 (estimated)
Completion
Apr 2021 (estimated)
Last update
Mar 30, 2020

Study contacts

Gema Serrano-Hernanz, PhD
Contact
gema.serrano.hernanz@gmail.com
669332986

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion